Clinical Trial Update: Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use [Phase 1]

View source ↗

Summary

A Phase 1 trial completed to evaluate the safety, pharmacokinetics, and acceptability of vaginally administered PC-1005 for HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PC-1005

Snippet

Sponsor: Population Council | Conditions: HIV | Phase 1 | Status: COMPLETED